Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques

Overview of attention for article published in The AAPS Journal, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 22 patents

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 54 Mendeley

So far, Altmetric has seen 22 patents that reference this research output.

Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques

About this Attention Score

Mentioned by

Citations

Readers on

Monospecific and multispecific anti-TMEFF2 antibodies and their uses

Grant US-11866499-B2

United States of America

Antibodies that specifically bind PD-1 and methods of use

Grant US-11746161-B2

United States of America

Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for…

Grant US-11433134-B2

United States of America

Anti-CCL17 antibodies

Grant US-11414484-B2

United States of America

Methods for purification of single domain antigen binding molecules

Grant US-11370835-B2

United States of America

Antibodies that specifically bind PD-1 and methods of use

Grant US-10995149-B2

United States of America

Protein formulations with increased stability

Grant US-10925965-B2

United States of America

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses

Grant US-10894830-B2

United States of America

Stable multi-dose compositions comprising an antibody and a preservative

Grant US-10835602-B2

United States of America

Anti-CCL17 antibodies

Grant US-10829549-B2

United States of America

Stable antibody containing compositions

Grant US-10709782-B2

United States of America

AQUEOUS FORMULATION OF ANTIBODY STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION

Application EP-3381445-A3

European Patent Office

Interferon alpha and omega antibody antagonists

Grant US-10155809-B2

United States of America

Formulations of single domain antigen binding molecules

Grant US-9993552-B2

United States of America

Anti-CCL17 antibodies

Grant US-9944697-B2

United States of America

Interferon alpha and omega antibody antagonists

Grant US-9902770-B2

United States of America

Stable antibody containing compositions

Grant US-9795674-B2

United States of America

Compositions and methods for preparation of poorly water soluble drugs with increased…

Grant US-9308180-B2

United States of America

Stabilized thrombin compositions

Grant US-8071090-B2

United States of America

Compositions and methods for preparation of poorly water soluble drugs with increased…

Grant US-8034765-B2

United States of America

Compositions and methods for preparation of poorly water soluble drugs with increased…

Grant US-7981445-B2

United States of America

Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial…

Grant US-7771751-B2

United States of America